(Q39138862)

9 September 2017

title

COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness (English)

1 reference

9 September 2017

main subject

neoplastic invasiveness

1 reference

Fengjuan Lin

1

1 reference

9 September 2017

Jianmin Luo

2

1 reference

9 September 2017

Wen Gao

3

1 reference

9 September 2017

Jiong Wu

4

1 reference

9 September 2017

Zhimin Shao

5

1 reference

9 September 2017

Ziliang Wang

6

1 reference

9 September 2017

Jiao Meng

7

1 reference

9 September 2017

Zhouluo Ou

8

1 reference

9 September 2017

Gong Yang

9

1 reference

9 September 2017

publication date

15 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

34

1 reference

9 September 2017

issue

5

1 reference

9 September 2017

page(s)

2817-2826

1 reference

9 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Targeting HER2 signaling pathway for radiosensitization: alternative strategy for therapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

COX-2 involvement in breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Expression of Cox-2 protein in radioresistant laryngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

p38 MAP kinase's emerging role as a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0840-X

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation

21 January 2018

1 reference

12 December 2020

Cell proliferation activity unrelated to COX-2 expression in ovarian tumors

1 reference

12 December 2020

p38α Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis.

1 reference

12 December 2020

Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor

1 reference

12 December 2020

Radiation-Triggered NF-κB Activation is Responsible for the Angiogenic Signaling Pathway and Neovascularization for Breast Cancer Cell Proliferation and Growth

1 reference

12 December 2020

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

12 December 2020

Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.

1 reference

12 December 2020

10.1007/S13277-013-0840-X

Identifiers

DOI

1 reference

9 September 2017

1 reference